Clinical Trials

Inclusion Criteria:

• Be aged above 18 for adult participants
• Be scheduled for ablation of a supraventricular tachycardia (SVT) or ventricular tachycardia (VT) due to the arrhythmia, poorly tolerated and/or unable to be controlled with antiarrhythmic drug therapy or being scheduled for transcatheter repair of SHD such as ASD/PFO closure, , or LAA occlusion
• Be able and willing to give informed consent

Exclusion Criteria:

• subjects who do not have any indication for above mentioned procedures
• subjects younger than 18 years of age
• incompetent subjects who cannot provide informed consent
• subjects from any vulnerable groups other than pediatric patients
• Pregnant or nursing subjects
• Subjects who are currently enrolled in any other clinical studies or have been participated in any drug or device studies in last 30 days of current procedure
• Subjects with any bleeding diathesis
• Subjects with known vascular abnormality rendering right heart catheterization from right or left femoral vein impossible.
• Subjects with known intracardiac thrombus
• Subjects with myocardial infarction within the prior two months
• Subjects with class IV angina or heart failure
• Subjects with sepsis or active infection
• Subjects with immune-deficiency or immune-compromised status
• Subjects with cerebral ischemic event in the prior six months
• Subjects with deep vein thrombosis

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 5/6/2024. Questions regarding updates should be directed to the study team contact.